Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Bonneau

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 2025
Impact of neoadjuvant immunotherapy on postoperative complications in oncoplastic breast cancer surgeryCapucine Barjot, Thomas Gaillard, Romain-David Seban, et al.
Annals of Surgical Oncology|June 23, 2026
Association Between Axillary Surgical Management and Survival for Patients With De Novo Metastatic Breast CancerEmilie Laude, Celian Guyon, Louna Mossino Diaz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 9, 2017
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breastMarion Lavigne, Emmanuelle Menet, Jean-Christophe Tille, et al.
Nature Communications|March 15, 2018
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancersAnne-Marie Givel, Yann Kieffer, Alix Scholer-Dahirel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2023
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumabRomain-David Seban, Emilie Arnaud, Delphine Loirat, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2018
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitisClaire Bonneau, Gilles Paintaud, Olivier Trédan, et al.
Cancer Research|November 12, 2025
An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 UpregulationIsabella Hofer, Yann Kieffer, Arianna Mencattini, et al.
Cancer Discovery|May 22, 2020
Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in CancerYann Kieffer, Hocine R Hocine, Géraldine Gentric, et al.
Clinical Breast Cancer|October 4, 2025
Effect of Breast Surgery on Quality of Life in BRCA Mutation Carriers With Invasive Breast Cancer: A CANTO Database StudyKatia Mahiou, Claire Bonneau, Charles Coutant, et al.
Radiology|September 3, 2024
Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant ChemoimmunotherapyToulsie Ramtohul, Victoire Lepagney, Claire Bonneau, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 2025
Impact of neoadjuvant immunotherapy on postoperative complications in oncoplastic breast cancer surgeryCapucine Barjot, Thomas Gaillard, Romain-David Seban, et al.
Annals of Surgical Oncology|June 23, 2026
Association Between Axillary Surgical Management and Survival for Patients With De Novo Metastatic Breast CancerEmilie Laude, Celian Guyon, Louna Mossino Diaz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 9, 2017
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breastMarion Lavigne, Emmanuelle Menet, Jean-Christophe Tille, et al.
Nature Communications|March 15, 2018
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancersAnne-Marie Givel, Yann Kieffer, Alix Scholer-Dahirel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2023
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumabRomain-David Seban, Emilie Arnaud, Delphine Loirat, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2018
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitisClaire Bonneau, Gilles Paintaud, Olivier Trédan, et al.
Cancer Research|November 12, 2025
An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 UpregulationIsabella Hofer, Yann Kieffer, Arianna Mencattini, et al.
Cancer Discovery|May 22, 2020
Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in CancerYann Kieffer, Hocine R Hocine, Géraldine Gentric, et al.
Clinical Breast Cancer|October 4, 2025
Effect of Breast Surgery on Quality of Life in BRCA Mutation Carriers With Invasive Breast Cancer: A CANTO Database StudyKatia Mahiou, Claire Bonneau, Charles Coutant, et al.
Radiology|September 3, 2024
Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant ChemoimmunotherapyToulsie Ramtohul, Victoire Lepagney, Claire Bonneau, et al.
Pageof 7